Bone Biologics Corporation (BBLG)Healthcare | Biotechnology | Burlington, United States | NasdaqCM
0.41 USD
-0.02
(-3.581%) ⇩
(Oct. 14, 2026, 4 p.m.
EDT)
After hours: 0.39 -0.03 (-0.027%) ⇩ (Oct. 14, 2026, 4:37 p.m. EDT) |
Hot Take ↕ | Oct. 10, 2026, 11:28 a.m. EDT
The immediate outlook is severely bearish as the stock trades at a fraction of its book value while facing a confirmed multi-year structural decline. Fundamentally, the company is in a precarious position with negative earnings, negative free cash flow, and a return on equity of nearly -55%, indicating severe capital destruction. Although the balance sheet shows a high current ratio, this liquidity is likely propped up by non-cash items or inventory rather than operational cash generation, given the massive operating cash burn. The recent news highlights a critical dependency on private placements to extend the runway to 2027, signaling that organic operations are insufficient to sustain the business without further dilution. While the stock recently rallied off its lows, the underlying fundamentals remain broken, and the lack of any dividend history confirms this is a pure speculative vehicle with no income component. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.505032 |
| MSTL | 0.506373 |
| AutoTheta | 0.510923 |
| AutoETS | 0.511046 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 35% |
| H-stat | 14.78 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.094 |
| Excess Kurtosis | -1.33 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 1,142,661 |
| Forward P/E | -0.62 |
| Beta | 0.57 |
| Website | https://www.bonebiologics.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8326848 |
| Address1 | 2 Burlington Woods Drive |
| Address2 | Suite 100 |
| All Time High | 10,255.68 |
| All Time Low | 0.391 |
| Ask | 0.6175 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 31,750 |
| Average Daily Volume3 Month | 383,346 |
| Average Volume | 383,346 |
| Average Volume10Days | 31,750 |
| Beta | 0.574 |
| Bid | 0.3265 |
| Bid Size | 2 |
| Book Value | 2.168 |
| City | Burlington |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.4146 |
| Current Ratio | 8.665 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 0.4146 |
| Day Low | 0.391 |
| Display Name | Bone Biologics |
| Dividend Date | 1,532,390,400 |
| Dividend Yield | 0.0 |
| Earnings Timestamp End | 1,754,942,400 |
| Earnings Timestamp Start | 1,754,596,800 |
| Ebitda Margins | 0.0 |
| Enterprise Value | -2,889,118 |
| Eps Current Year | -1.23 |
| Eps Forward | -0.67 |
| Eps Trailing Twelve Months | -1.37 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.59262 |
| Fifty Day Average Change | -0.17802 |
| Fifty Day Average Change Percent | -0.30039486 |
| Fifty Two Week Change Percent | -83.26848 |
| Fifty Two Week High | 2.7 |
| Fifty Two Week High Change | -2.2854 |
| Fifty Two Week High Change Percent | -0.84644437 |
| Fifty Two Week Low | 0.391 |
| Fifty Two Week Low Change | 0.023600012 |
| Fifty Two Week Low Change Percent | 0.06035809 |
| Fifty Two Week Range | 0.391 - 2.7 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,634,131,800,000 |
| Float Shares | 2,755,396 |
| Forward Eps | -0.67 |
| Forward P E | -0.618806 |
| Free Cashflow | -1,686,114 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 2 |
| Fullday Change | -0.041999996 |
| Fullday Change Percent | -9.767441 |
| Fullday Price | 0.4146 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00024000001 |
| Held Percent Institutions | 0.05014 |
| Implied Shares Outstanding | 2,756,057 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-10-13 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,749,513,600 |
| Last Split Factor | 1:6 |
| Long Business Summary | Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts. |
| Long Name | Bone Biologics Corporation |
| Market | us_market |
| Market Cap | 1,142,661 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_99330767 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -2,891,070 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,395,391 |
| Number Of Analyst Opinions | 1 |
| Open | 0.407 |
| Operating Cashflow | -2,628,868 |
| Operating Margins | 0.0 |
| Phone | 781 552 4452 |
| Post Market Change | -0.026600003 |
| Post Market Change Percent | -6.415823 |
| Post Market Price | 0.388 |
| Post Market Time | 1,792,010,236 |
| Previous Close | 0.43 |
| Price Eps Current Year | -0.33707318 |
| Price Hint | 4 |
| Price To Book | 0.19123617 |
| Profit Margins | 0.0 |
| Quick Ratio | 7.888 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0154 |
| Regular Market Change Percent | -3.58139 |
| Regular Market Day High | 0.4146 |
| Regular Market Day Low | 0.391 |
| Regular Market Day Range | 0.391 - 0.4146 |
| Regular Market Open | 0.407 |
| Regular Market Previous Close | 0.43 |
| Regular Market Price | 0.4146 |
| Regular Market Time | 1,792,008,001 |
| Regular Market Volume | 58,147 |
| Return On Assets | -0.33455002 |
| Return On Equity | -0.5496 |
| Sand P52 Week Change | 0.1570785 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 2,756,057 |
| Shares Percent Shares Out | 0.018 |
| Shares Short | 49,512 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 36,999 |
| Short Name | Bone Biologics Corp |
| Short Percent Of Float | 0.018 |
| Short Ratio | 0.17 |
| Source Interval | 15 |
| State | MA |
| Symbol | BBLG |
| Target High Price | 12.2 |
| Target Low Price | 12.2 |
| Target Mean Price | 12.2 |
| Target Median Price | 12.2 |
| Total Cash | 4,031,780 |
| Total Cash Per Share | 1.463 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.37 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.1377 |
| Two Hundred Day Average Change | -0.72309995 |
| Two Hundred Day Average Change Percent | -0.63558054 |
| Type Disp | Equity |
| Volume | 58,147 |
| Website | https://www.bonebiologics.com |
| Zip | 1,803 |